reference/18130673

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18130673

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, N.I.H., Extramural\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	253
issn	0920-1211
issueIdentifier	2-3
pageRange	245-253
publicationName	Epilepsy Research
startingPage	245
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a2093a60d794558f869db0c777032211 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9cf714aefb481369b6c8c5620290909c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bdb91aa4214d1e40f92cecc9ab5c2edb
bibliographicCitation	Okulicz JF, Grandits GA, French JA, Perucca E, George JM, Landrum ML, Acosta EP, Birbeck GL. The impact of enzyme-inducing antiepileptic drugs on antiretroviral drug levels: A case-control study. Epilepsy Research. 2013 Feb;103(2-3):245–53. doi: 10.1016/j.eplepsyres.2012.07.009.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae71b436f531ea667d56cc5d9981e1e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_980f12f3c9c987a1be8d6e28e4f18ee9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bfa614f9b30d2379aa07b7fe6722e26d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_513473bc72f03e3def290d5483082b28 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c6037fa458a9e0ba7b7854119a68d519 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_647a04f77367490955497d5d4159734e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6abe8a66cfe805ef995a54569be3a990 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ba7c8a2c69050a1096ebde093ae38a9
date	201302
identifier	https://doi.org/10.1016/j.eplepsyres.2012.07.009 https://pubmed.ncbi.nlm.nih.gov/22835761 https://pubmed.ncbi.nlm.nih.gov/PMC3508295
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587 https://portal.issn.org/resource/ISSN/0920-1211
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	The impact of enzyme-inducing antiepileptic drugs on antiretroviral drug levels: A case-control study
discusses	http://id.nlm.nih.gov/mesh/M0001382 http://id.nlm.nih.gov/mesh/M0446823
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D044966Q000097 http://id.nlm.nih.gov/mesh/D000927Q000097 http://id.nlm.nih.gov/mesh/D015658Q000201
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016022 http://id.nlm.nih.gov/mesh/D044966Q000627 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D015658Q000188 http://id.nlm.nih.gov/mesh/D000927Q000627 http://id.nlm.nih.gov/mesh/D004790Q000502 http://id.nlm.nih.gov/mesh/D015658Q000097 http://id.nlm.nih.gov/mesh/D004790Q000187 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D004347Q000502
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1775 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2554

Total number of triples: 50.